Purabi General Insurance Company Limited (DSE:PURABIGEN)
Bangladesh · Delayed Price · Currency is BDT 17.90
+0.10 (0.56%)
At close: Aug 11, 2025
Elevation Oncology Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2020 |
Premiums & Annuity Revenue | -31.51 | - | - | 57.9 | 81.85 | 24.02 | Upgrade |
Total Interest & Dividend Income | 159.57 | 150.17 | 103.33 | 91.77 | 64.66 | 87.08 | Upgrade |
Gain (Loss) on Sale of Investments | -3.91 | -1.71 | 5.56 | 11.99 | 16.68 | 2.2 | Upgrade |
Other Revenue | 1.86 | - | - | 18.66 | 12.42 | 8.71 | Upgrade |
Total Revenue | 126.01 | 148.45 | 108.89 | 180.33 | 175.61 | 122.01 | Upgrade |
Revenue Growth (YoY) | -14.72% | 36.34% | -39.62% | 2.69% | 43.92% | 13.78% | Upgrade |
Policy Benefits | -14.47 | - | - | -4.37 | 24.04 | 1.8 | Upgrade |
Policy Acquisition & Underwriting Costs | -0.75 | - | - | 17.19 | 5.64 | 3.04 | Upgrade |
Depreciation & Amortization | 3.98 | 3.98 | 2.01 | 1.51 | 0.91 | 1.09 | Upgrade |
Selling, General & Administrative | 4.59 | 4.15 | 3.6 | 35.91 | 28.19 | 14.04 | Upgrade |
Total Operating Expenses | -6.66 | 8.12 | 5.61 | 50.25 | 58.77 | 19.97 | Upgrade |
Operating Income | 132.68 | 140.33 | 103.28 | 130.08 | 116.83 | 102.05 | Upgrade |
Interest Expense | -0.81 | -0.81 | -0.65 | -4.97 | -1.39 | -2.31 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | - | -0.15 | - | Upgrade |
EBT Excluding Unusual Items | 131.86 | 139.52 | 102.63 | 125.11 | 115.29 | 99.73 | Upgrade |
Gain (Loss) on Sale of Assets | 0.11 | 0.11 | 0.28 | - | - | - | Upgrade |
Pretax Income | 131.97 | 139.63 | 102.91 | 125.11 | 115.29 | 99.73 | Upgrade |
Income Tax Expense | 47.12 | 47.79 | 31.98 | 41.41 | 35.57 | 35.76 | Upgrade |
Net Income | 84.86 | 91.84 | 70.92 | 83.71 | 79.72 | 63.97 | Upgrade |
Net Income to Common | 84.86 | 91.84 | 70.92 | 83.71 | 79.72 | 63.97 | Upgrade |
Net Income Growth | -12.40% | 29.49% | -15.27% | 4.99% | 24.62% | 9.86% | Upgrade |
Shares Outstanding (Basic) | 60 | 60 | 60 | 60 | 60 | - | Upgrade |
Shares Outstanding (Diluted) | 60 | 60 | 60 | 60 | 60 | - | Upgrade |
EPS (Basic) | 1.42 | 1.54 | 1.19 | 1.40 | 1.33 | - | Upgrade |
EPS (Diluted) | 1.42 | 1.54 | 1.19 | 1.40 | 1.33 | - | Upgrade |
EPS Growth | -12.40% | 29.49% | -15.27% | 4.99% | - | - | Upgrade |
Free Cash Flow | 97.93 | 86.74 | 64.51 | 210.48 | 61.71 | 85.05 | Upgrade |
Free Cash Flow Per Share | 1.64 | 1.45 | 1.08 | 3.52 | 1.03 | - | Upgrade |
Dividend Per Share | 1.000 | 1.000 | 1.000 | 0.680 | 0.971 | 0.485 | Upgrade |
Dividend Growth | - | - | 47.14% | -30.00% | 100.02% | -56.26% | Upgrade |
Operating Margin | 105.29% | 94.53% | 94.85% | 72.14% | 66.53% | 83.64% | Upgrade |
Profit Margin | 67.34% | 61.86% | 65.14% | 46.42% | 45.40% | 52.43% | Upgrade |
Free Cash Flow Margin | 77.72% | 58.43% | 59.25% | 116.72% | 35.14% | 69.70% | Upgrade |
EBITDA | 134.9 | 142.26 | 105.29 | 131.59 | 117.74 | 102.23 | Upgrade |
EBITDA Margin | 107.05% | 95.83% | 96.69% | 72.97% | 67.05% | 83.79% | Upgrade |
D&A For EBITDA | 2.23 | 1.93 | 2.01 | 1.51 | 0.91 | 0.18 | Upgrade |
EBIT | 132.68 | 140.33 | 103.28 | 130.08 | 116.83 | 102.05 | Upgrade |
EBIT Margin | 105.29% | 94.53% | 94.85% | 72.14% | 66.53% | 83.64% | Upgrade |
Effective Tax Rate | 35.70% | 34.23% | 31.08% | 33.09% | 30.85% | 35.85% | Upgrade |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.